BWS
CYTK icon

Buck Wealth Strategies’s Cytokinetics CYTK Stock Holding History

Buck Wealth Strategies’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$170 Buy
+2
New +$144 ﹤0.01% 1099
2023
Q4 		– Sell
-57
Closed -$1.68K – 122
2023
Q3 		$1.68K Hold
57
– – ﹤0.01% 318
2023
Q2 		$1.86K Hold
57
– – ﹤0.01% 240
2023
Q1 		$2.01K Buy
+57
New +$2.33K ﹤0.01% 182

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Buck Wealth Strategies's CYTK Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Cytokinetics (CYTK) in Q2 2026: 2 shares worth $170. The stake represents ﹤0.01% of the portfolio and ranks #1099 among its holdings. This is a return to the name: Buck Wealth Strategies previously reported a position in CYTK as recently as Q3 2023.

Buck Wealth Strategies first reported a position in CYTK in Q1 2023 and has held it in 4 quarters since. The position peaked at $2.01K in Q1 2023. 484 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Buck Wealth Strategies held 2 shares of Cytokinetics worth $170 as of Q2 2026.
  • Cytokinetics was a new Buck Wealth Strategies position in Q2 2026.
  • Cytokinetics made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #1099 holding.
  • Buck Wealth Strategies first reported a position in Cytokinetics in Q1 2023 and has held it in 4 quarters since.
  • Buck Wealth Strategies's Cytokinetics position peaked at $2.01K in Q1 2023.
  • 484 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.